DE69503302D1 - Verwendung von Fibrinkleber in der nicht-chirurgischen Behandlung von Hartincontinenz - Google Patents

Verwendung von Fibrinkleber in der nicht-chirurgischen Behandlung von Hartincontinenz

Info

Publication number
DE69503302D1
DE69503302D1 DE69503302T DE69503302T DE69503302D1 DE 69503302 D1 DE69503302 D1 DE 69503302D1 DE 69503302 T DE69503302 T DE 69503302T DE 69503302 T DE69503302 T DE 69503302T DE 69503302 D1 DE69503302 D1 DE 69503302D1
Authority
DE
Germany
Prior art keywords
fibrin glue
incontinence
hard
surgical treatment
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69503302T
Other languages
English (en)
Other versions
DE69503302T2 (de
Inventor
Angelo Pinto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69503302D1 publication Critical patent/DE69503302D1/de
Publication of DE69503302T2 publication Critical patent/DE69503302T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815Carrier is a synthetic polymer
    • Y10S530/817Entrapped within the carrier, e.g. gel, hollow fibre

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69503302T 1994-04-28 1995-04-26 Verwendung von Fibrinkleber in der nicht-chirurgischen Behandlung von Hartincontinenz Expired - Fee Related DE69503302T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT94SA000004A ITSA940004A1 (it) 1994-04-28 1994-04-28 Uso della colla di fibrina umana per l'incontinenza urinaria e nel reflusso vescico-ureterale

Publications (2)

Publication Number Publication Date
DE69503302D1 true DE69503302D1 (de) 1998-08-13
DE69503302T2 DE69503302T2 (de) 1998-12-10

Family

ID=11407471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69503302T Expired - Fee Related DE69503302T2 (de) 1994-04-28 1995-04-26 Verwendung von Fibrinkleber in der nicht-chirurgischen Behandlung von Hartincontinenz

Country Status (6)

Country Link
US (1) US5700783A (de)
EP (1) EP0679404B1 (de)
AT (1) ATE168012T1 (de)
DE (1) DE69503302T2 (de)
ES (1) ES2120705T3 (de)
IT (1) ITSA940004A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572532B1 (en) * 1999-03-01 2003-06-03 Advanced Biomedical Devices Inc. Implant positioning system and method
EP1748803A2 (de) * 2004-05-27 2007-02-07 Humanitas Mirasole S.p.A. Verwendung von fibrin zur trennung von körperorganen
MD4163C1 (ro) * 2010-12-23 2012-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos sub formă de gel pentru profilaxia complicaţiilor postoperatorii
CN114159471A (zh) * 2020-09-11 2022-03-11 永立荣生医股份有限公司 包括羊水干细胞球的医药组合物及其治疗尿失禁的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516532A (en) * 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation

Also Published As

Publication number Publication date
ATE168012T1 (de) 1998-07-15
US5700783A (en) 1997-12-23
EP0679404A3 (de) 1996-05-15
ITSA940004A1 (it) 1995-10-28
EP0679404B1 (de) 1998-07-08
EP0679404A2 (de) 1995-11-02
ITSA940004A0 (it) 1994-04-28
ES2120705T3 (es) 1998-11-01
DE69503302T2 (de) 1998-12-10

Similar Documents

Publication Publication Date Title
DE69730835D1 (de) Methode zur verhinderung von hautreizungen durch fäkale enzyme
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
ATE275608T1 (de) Behandlung von mineralfüllstoffen mit phosphaten, diese füllstoffe und deren verwendung
ATE197067T1 (de) Plasminogen-aktivator-rezeptor vom urokinasetyp
ATE444086T1 (de) Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln
FR2750863B1 (fr) Utilisation d'un polyholoside dans une composition destinee a favoriser la desquamation de la peau, et composition la comprenant
AU2883689A (en) The use of moclobemide to treat or prevent cognitive disorders
DE69503302D1 (de) Verwendung von Fibrinkleber in der nicht-chirurgischen Behandlung von Hartincontinenz
ATE440614T1 (de) Nicht-neurotoxische plasminogen aktivierende faktoren zur behandlung von schlaganfällen
ES2085326T3 (es) Activador de plasminogeno salivar del murcielago vampiro vpa-alfa1.
ATE471985T1 (de) Protease from lucilia sericata und deren verwendung zur wundheilung
ATE120645T1 (de) Verfahren und therapeutische zubereitungen für die behandlung von gerinnungsstörungen.
DE60140864D1 (de) Therapeutische zusammenfassungen und verfahren zur modulierung von v3, eine isoform von versican
DE60021111D1 (de) Verwendung von fibrinolytischen metallproteinasen zur behandlung von blutgerinseln
DE59813914D1 (de) Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen
ID23176A (id) Metoda untuk mengobati gangguan pembuluh darah
DE60128130D1 (de) Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a
ATE353666T1 (de) Verwendung von aktiviertem gerinnungsfaktor vii zur behandlung von durch thrombolytische therapie-induzierten wichtigen blutungen
EP0795333A3 (de) TGF-beta regulierender Stoff zur Behandlung der Myopia oder Hyperopia
PT935616E (pt) Adesivos com teores baixos em monomeros residuais e processo para o seu fabrico
ATE271878T1 (de) Verwendung von protein h als zytostattischer wirkstoff
GB9906285D0 (en) Improvements in or relating to personal hygiene
ES2173158T3 (es) Reduccion del tejido adiposo utilizando colagenasa
IL109735A0 (en) Tissue plasminogen activator having zymonogenic or fibrin specific properties

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee